跳至主要内容
临床试验/JPRN-jRCT2080220136
JPRN-jRCT2080220136未知3 期

Clinical investigation for combination therapy of KAD-1229 and Pioglitazone.

KISSEI PHARMACEUTICAL CO.,LTD.0 个研究点开始时间: 2005年10月3日最近更新:
适应症

试验速览

阶段
3 期

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • Main Inclusion Criteria:
  • - Type 2 diabetic outpatients, aged 20 years or older, who are treated with diet and stable dose of pioglitazone monotherapy.
  • - HbA1c and post prandial glucose are within a certain range

排除标准

  • - Patients who require treatment with insulin.
  • - Patients complicated with severe diabetic microangiopathy (neuropathy, retinopathy or nephropathy).
  • - Patients complicated with severe cardiac disease, hepatic disease, renal disease or hypertension.

研究者

相似试验

Clinical investigation for combination therapy of... | 临床试验